| JPM |
Report |
Adjusted EPS |
BEAT |
pred ~$5.75 vs. cons $5.61 |
MEDIUM |
| JPM |
Report |
Markets revenue |
BEAT |
pred ~$10.25B vs. cons $10.00B |
MEDIUM |
| JPM |
Report |
Net interest income |
IN-LINE |
pred ~$25.75B vs. cons $25.60B |
MEDIUM |
| JPM |
Guide |
Net interest income excluding Markets |
BETTER |
guide ~$95.5B vs. cons $95.0B (FY2026) |
MEDIUM |
| JPM |
Guide |
Adjusted expenses |
LOWER |
guide ~$106.5B vs. cons $106.0B (FY2026) |
MEDIUM |
| JPM |
Guide |
Card net charge-off rate |
UNCHANGED |
guide ~3.4% vs. cons 3.4% (FY2026) |
HIGH |
| JPM |
Return |
Day-1 residual (stock − beta × S&P 500) |
-1.3% |
— |
MEDIUM |
| JPM |
Return |
5-day cumulative residual |
-1.8% (FOLLOW-THROUGH) |
Elevated buy-side expectations limit credit for the trading beat; higher expenses offset the modest NII upgrade, leaving 2026–2027 EPS revisions near ~0% versus ~2% headline EPS upside and encouraging continued de-risking after day 1. |
MEDIUM |